Market Overview
The veterinary lasers market covers devices that deliver controlled optical energy for therapeutic rehabilitation, dermatological treatment, and surgical interventions in animal healthcare settings. Estimates for 2025 global market size range from approximately USD 340 million to USD 412 million across independent research sources, reflecting normal variance in scope and methodology. Projections through 2030-2034 converge on a market value between USD 760 million and USD 786 million, implying compound annual growth rates between 8.4% and 10.7%.
- •Market valued at roughly USD 413 million in 2025, with forecasts reaching USD 760-790 million by 2031-2034
- •Compound annual growth rates cited across sources range from 8.4% to 10.7%
- •Covers companion animals (dogs, cats), equines, and increasingly exotic and livestock species
Growth Drivers
The primary engine of market growth is the expanding companion animal population and rising per-animal healthcare spending, particularly in North America and Europe, where pets are increasingly treated as family members. Low-level laser therapy has gained clinical credibility for managing post-operative pain, treating chronic musculoskeletal conditions, and accelerating wound healing, which broadens its adoption beyond specialty referral centers into general veterinary practice. Additional support comes from manufacturers offering more compact, user-friendly systems at lower price points, reducing the capital barrier for mid-sized and independent clinics.
- •Rising pet insurance penetration and overall veterinary expenditure amplify willingness to invest in advanced treatment modalities
- •Clinical evidence supporting LLLT for pain management, inflammation reduction, and tissue repair continues to accumulate
- •Technological miniaturization and falling unit costs are expanding the addressable market beyond large referral hospitals
Segmentation and Regional Analysis
The market is typically segmented by product type into cold-laser (low-level) therapy devices and surgical laser systems, as well as by end user type including hospitals and clinics, ambulatory surgical centers, and research institutions. Geographically, North America holds the largest share, supported by high veterinary spending, favorable reimbursement environments, and a well-developed distribution infrastructure. Europe represents a substantial and growing segment, with some regional estimates placing it significantly above other geographies. Asia-Pacific and Latin America are the fastest-growing regions on a percentage basis, driven by rising middle-class pet ownership and expanding veterinary service networks.
- •North America commands the largest regional share, with Europe following as the second major market
- •Asia-Pacific and Latin America are emerging as high-growth regions, albeit from smaller current bases
- •Product segmentation spans low-level therapy lasers for rehabilitation and higher-power surgical lasers for operative procedures
Competitive Landscape
Who are the notable companies in the industry?
**Competitive Landscape** The veterinary lasers market is moderately fragmented, shaped by a mix of diversified medical technology firms with veterinary divisions and smaller specialty producers focused on animal-health laser systems. Identified industry leaders include Aesculight LLC (USA), AngioDynamics Inc. (USA), BISON MEDICAL Co. Ltd. (South Korea), Cutting Edge Laser Technologies (USA), DEKA M.E.L.A. srl (Italy), Elenza Inc. (USA), and Excel Technologies Ltd. (Israel), alongside additional profiled players such as BIOLASE Inc. (USA) operating within broader medical device portfolios. Competitive positioning typically varies by origin: Italy-based DEKA M.E.L.A. and South Korea-based BISON MEDICAL contribute from established European and Asian manufacturing bases, while Israel-based Excel Technologies extends the field's geographic reach. To capture larger market share, players are deploying strategic initiatives such as product improvements, regional expansion, distribution alliances, collaborations, and mergers and acquisitions. Differentiation is driven less by raw laser physics, since the field relies on mature optical platforms, and more by device engineering, software integration, and veterinary-specific clinical protocols.
- •Market is moderately fragmented, with both integrated medical technology firms and specialty veterinary-laser producers coexisting
- •Core laser technologies span solid-state diode systems, Nd:YAG, and CO2 platforms, with differentiation centered on device design and clinical workflow integration
- •Manufacturing and R&D activity is concentrated in North America and Western Europe, with growing regional assembly and distribution capacity in Asia-Pacific
Trends and Outlook
What are the recent trends and outlook?
Several structural trends are shaping the trajectory of the veterinary lasers market. Multipurpose, compact systems that combine diagnostic and therapeutic capabilities are gaining favor in space-constrained general-practice environments. Concurrently, veterinary practitioners and pet owners are showing increased interest in holistic and minimally invasive treatment options, reinforcing the case for laser-based modalities over more aggressive pharmaceutical or surgical alternatives. Looking forward, continued product innovation, expansion into emerging veterinary markets, and broader clinical validation of laser applications are expected to sustain the market's double-digit growth momentum through the end of the decade.
- •Compact, multi-function laser systems are becoming a priority for general veterinary practices seeking versatile equipment
- •Growing emphasis on minimally invasive, drug-free treatment modalities aligns with broader trends in veterinary medicine
- •Market is expected to sustain solid growth through 2030-2031 as clinical evidence and practitioner familiarity deepen
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2026 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.